Euda Health Limited and Subsidiaries Index to Unaudited Condensed Consolidated Financial Statements Condensed Consolidated Balance Sheets as of

Health Limited and Subsidiaries

to Unaudited Condensed Consolidated Financial Statements

HEALTH LIMITED AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

HEALTH LIMITED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

HEALTH LIMITED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGE IN SHAREHOLDERS' EQUITY (DEFICIT)

accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

HEALTH LIMITED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

HEALTH LIMITED AND SUBSIDIARIES

TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars, unless stated otherwise)

1- Nature of business and organization

Health Limited ("EHL" or the "Company") is a holding company incorporated on June 8, 2021, under the laws of

British Virgin Islands ("BVI"). The Company has no substantive operations other than holding all of the outstanding shares

of its subsidiaries through a reverse recapitalization.

Company, through its subsidiaries, operates its business in two segments, 1) engaged in the healthcare specialty group (other than general

practice) business offering range of specialty care services to patients, and engaged in the medical facility general practice clinic

that provides holistic care for various illnesses, and 2) engaged in the property management service that services shopping malls, business

office building, or residential apartments.

August 3, 2021, EHL completed a reverse recapitalization ("Reorganization") under common control of its then existing shareholders,

who collectively owned all of the equity interests of Kent Ridge Health Private Limited ("KRHPL"), a holding company incorporated

under the laws of the Singapore prior to the Reorganization, through the following transaction.

and after the Reorganization, the Company, together with its subsidiaries (as indicated above), is effectively controlled by the same

shareholders, and therefore the Reorganization is considered as a recapitalization of entities under common control in accordance with

Accounting Standards Codification ("ASC") 805-50-25. The consolidation of the Company and its subsidiaries have been accounted

for at historical cost and prepared on the basis as if the aforementioned transactions had become effective as of the beginning of the

first period presented in the accompanying unaudited condensed consolidated financial statements in accordance with ASC 805-50-45-5.

to the Reorganization, KRHPL entered into a Sales and Purchase of Shares Agreement ("KRHSG Agreement") with the sole shareholder

of KRHSG who is under common control of the majority shareholders of KRHPL on December 2, 2019. Pursuant to the KRHSG Agreement, KRHPL

will acquire 100% of the equity interests in KRHSG ("Reorganization of KRHSG") for a total consideration of SG$1.0 ("Total

Consideration"). The transaction was completed and effective on January 3, 2020. Since KRHSG and KRHPL are effectively controlled

by the same shareholders of EHL, and therefore the Reorganization is under common control at carrying value. The financial statements

of KRHSG are prepared on the basis as if the restructuring of KRHSG became effective as of the beginning of the first period presented

in the accompanying unaudited condensed consolidated financial statements of EHL.

to the Reorganization, KRHPL entered into a Sales and Purchase of Shares Agreement ("EUDA PL Agreement") with the sole shareholder

of EUDA PL who is under common control of the majority shareholders of KRHPL on December 2, 2019. Pursuant to the EUDA PL Agreement,

KRHPL will acquire 100% of the equity interests in EUDA PL ("Reorganization of EUDA PL") for a total consideration of SG$1.0

("Total Consideration"). The transaction was completed and effective on January 3, 2020. Since EUDA PL and LRHPL are effectively

controlled by the same shareholders of EHL, and therefore the Reorganization is under common control at carrying value. The financial

statements of EUDA PL are prepared on the basis as if the restructuring of EUDA PL became effective as of the beginning of the first

period presented in the accompanying unaudited condensed consolidated financial statements of EHL.

to the Reorganization, KRHPL entered into a Sales and Purchase of Shares Agreement ("SEMA Agreement") with the sole shareholder

of SEMA who is effectively controlled by the same shareholders of KRHPL on December 31, 2019. Pursuant to the SEMA PL Agreement, KRHPL

will acquire 100% of the equity interests in SEMA ("Reorganization of SEMA") for no consideration. SEMA is a holding company

and has no operations prior to December 31, 2019.

accompanying consolidated unaudited condensed financial statements reflect the activities of EHL and each of the following entities:

April 11, 2022, the Company entered into a Share Purchase Agreement (the "SPA") with 8i Acquisition 2 Corp. ("8i Acquisition"),

a British Virgin Islands company for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization,

reorganization or other similar business combination with one or more businesses or entities. Pursuant to the terms of the SPA, a business

combination between the Company and 8i Acquisition will be effected through the issuance of 8i Acquisition's ordinary shares to

the Company's existing shareholders in exchange of all of Company's outstanding ordinary shares (the "Share Purchase")

based on the purchase price as discussed below. Upon the closing of the SPA, the business combination will be accounted for as a reverse

recapitalization in accordance with U.S. GAAP. Under this method of accounting, 8i Acquisition will be treated as the "acquired"

company and the Company will be treated as the accounting acquirer for financial statement reporting purposes. Accordingly, the business

combination will be treated as the equivalent of the Company issuing shares for the net assets of 8i Acquisition, accompanied by a recapitalization.

The net assets of 8i Acquisition will be stated at historical cost, with no goodwill or other intangible assets recorded. Operations

prior to the business combination will be those of the Company.

Meng Dong (James) Tan, who owns 33.3% of the equity interests of the Company through Watermark

Developments Limited ("Seller"), the sole shareholder of the Company, is the Chief Executive Officer and Chairman

of 8i Acquisition's board of directors. 8i Acquisition received a fairness opinion from EverEdge Global to the effect that the

purchase price to be paid by 8i Acquisition for the shares of the Company pursuant to the SPA is fair to 8i Acquisition from a financial

point of view (the "Fairness Opinion").

connection with the closing of the transactions under the SPA, the current officers and directors of the Company will become 8i Acquisition's

officers and directors.

May 30, 2022, Amendment No. 1 (the "Amendment") was made to the SPA. Pursuant to the Amendment, 8i Acquisition shall have

completed its financial, operational and legal due diligence review of the Company (the Due Diligence Review") on or before June

15, 2022, and be satisfied with the results of the Due Diligence Review. If 8i Acquisition has not notified Watermark Developments limited,

a British Virgin Islands business company (the "Seller") in writing that it is not satisfied with the results of its Due

Diligence Review by close of business, New York time, on June 15, 2022, the closing condition of Section 9.2(j) from the SPA shall lapse

without the necessity of any further action by the parties."

June 10, 2022, the Company, the Seller, and 8i Acquisition

entered into a second amendment of the SPA (the "Second Amendment").

to the Second Amendment, the initial consideration to be paid at closing (the "Closing") of the Share Purchase (the "Initial

Consideration") by 8i Acquisition to

Seller for the Share Purchase will be adjusted to an amount equal to $140,000,000. The Initial Consideration will be payable in ordinary

shares of 8i Acquisition, no par value, (the "Purchaser Shares") valued at $10.00

per share. To secure Seller's obligations under the indemnification provisions of the SPA, 1,400,000 Purchaser Shares (the "Indemnification

Escrow Shares") shall be withheld from the Purchaser Shares payable at Closing, and be delivered to American Stock Transfer &

Trust Company, as Escrow Agent, and held by the Escrow Agent pursuant to an escrow agreement, by and among 8i Acquisition,

Seller, and the Indemnified Party Representative.

to the Second Amendment, in addition to the Initial Consideration, the Seller may also receive up to 4,000,000 additional Purchaser Shares

as an earnout payment (the "Earnout Shares") if, during the period beginning on the date of Closing and ending on December

31, 2024, the volume-weighted average price of Purchaser Shares (the "Purchaser Share Price") equals or exceeds any of four

thresholds over any 20 trading days within a 30-day trading period under the terms and conditions set forth in the SPA and related transaction

The Seller will be issued 1,000,000 additional Purchaser Shares if during the period beginning on the Closing Date and ending on the